Adenine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled study
Authors:
- M.F. BassendineMBM.F. Bassendine
- R.G. ChadwickRCR.G. Chadwick
- J. SalmeronJSJ. Salmeron
- U. ShiptonUSU. Shipton
- H.C. ThomasHTH.C. Thomas
- S. SherlockSSS. Sherlock
- 1 May 1981
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 80 (5) , 1016-1022
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- DOUBLE-BLIND STUDY OF LEUCOCYTE INTERFERON ADMINISTRATION IN CHRONIC HBsAg-POSITIVE HEPATITISThe Lancet, 1980
- Fibroblast interferon treatment of a patient with chronic active hepatitisThe American Journal of Medicine, 1979
- Trial of ribavirin for the treatment of HBsAg positive chronic liver diseaseJournal of Antimicrobial Chemotherapy, 1978
- Adenine Arabinoside Therapy of Biopsy-Proved Herpes Simplex EncephalitisNew England Journal of Medicine, 1977
- Type B Hepatitis: The Infectivity of Blood Positive for E Antigen and DNA Polymerase after Accidental Needlestick ExposureNew England Journal of Medicine, 1976
- Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active HepatitisNew England Journal of Medicine, 1976
- Adenine Arabinoside Therapy of Herpes Zoster in the ImmunosuppressedNew England Journal of Medicine, 1976
- INTEGRATOR ENZYME HYPOTHESIS FOR REPLICATION OF HEPATITIS-B VIRUSThe Lancet, 1975
- D.N.A. POLYMERASE IN PREPARATIONS CONTAINING AUSTRALIA ANTIGENThe Lancet, 1971
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966